Briviact
NDC 50474-970, brivaracetam, injection, suspension, from UCB, Inc..
- Product NDC
- 50474-970
- Status
- Listed
- Labeler
- UCB, Inc.
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA205837
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/50474-970 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BRIVARACETAM50 mg/5mL
Pharmacologic classes
Epoxide Hydrolase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50474-970-75 | 50474097075 | 10 VIAL, GLASS in 1 CARTON (50474-970-75) / 5 mL in 1 VIAL, GLASS (50474-970-63) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3cf2f439-0e97-443e-8e33-25ecef616f6c
Use it
Look up 50474-970 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50474-970 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50474-970. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.